ecrin-mdr-crcClinical2003Lung CancerColorectal CancerHead and Neck CancerProstate CancerBreast CancerHead and Neck NeoplasmsCancerLung CancerColorectal CancerProstate CancerHead And Neck NeoplasmsHead And Neck CancerBreast CancerCancerInterventionalhttps://newmdr.ecrin.org/Study/2008862United States2TumorFluorouracilECRIN MDRCompletedfalseSafety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid TumorsThis is a Phase I, multi-center study of GM-CT-01, which has been shown to increase the anti-tumor activity of 5-fluorouracil in mice. The primary reason for doing the study is to determine the safety of GM-CT-01 given alone and in combination with therapeutical dosage of 5-Fluorouracil, in patients who have advanced cancer that can be measured by CT scan.2003-02-152008862NCT00054977